Pancreatic cancer cells were used to verify the in vitro and in vivo effects of solasonine. Metabolomics were used to evaluate its underlying mechanisms. Solasonine promoted PANC-1 and CFPAC-1 cell apoptosis while inhibiting their proliferation, migration and invasion.
[Frontiers in Oncology]
6445212
BBBBBBBB
items
1
apa
0
default
asc
1
174008
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
